Denise Pollard-Knight

Denise Pollard-Knight discloses dealings in 2 companies, chiefly OncoMed Pharmaceuticals Inc and Albireo Pharma, Inc. Over a trading history stretching from 23 July 2013 to 3 November 2016, the count stands at 17 filings.

Both buying and selling appear: 1 purchase worth €756k, against 14 sales worth €3.2M. On balance, insiders were net sellers of €2.4M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 1 share grant.

The latest filing, published on 7 November 2016, reports a share grant in Albireo Pharma, Inc. The last purchase on record was published on 23 July 2013, which is 4,857 days ago. Typically, a trade is published a median of 1 day after it takes place. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.